Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2243 | 2310 | 38.3 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
2243 | 1 | CYCLOOXYGENASE//PROSTAGLANDIN H SYNTHASE//AB HANCOCK JR MEM CANC | 2310 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE | authKW | 308946 | 12% | 8% | 285 |
2 | PROSTAGLANDIN H SYNTHASE | authKW | 202701 | 2% | 34% | 45 |
3 | AB HANCOCK JR MEM CANC | address | 175488 | 1% | 40% | 33 |
4 | COX 2 INHIBITORS | authKW | 169778 | 4% | 14% | 90 |
5 | COX 1 | authKW | 111621 | 2% | 16% | 54 |
6 | 1 5 DIARYLPYRAZOLES | authKW | 94066 | 0% | 65% | 11 |
7 | COX 2 | authKW | 89420 | 6% | 5% | 147 |
8 | PROSTAGLANDIN ENDOPEROXIDE SYNTHASE | authKW | 82223 | 1% | 27% | 23 |
9 | IMRECOXIB | authKW | 79302 | 0% | 100% | 6 |
10 | SELECTIVE COX 2 INHIBITORS | authKW | 78192 | 1% | 31% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 16467 | 25% | 0% | 584 |
2 | Biochemistry & Molecular Biology | 4834 | 39% | 0% | 912 |
3 | Pharmacology & Pharmacy | 2066 | 19% | 0% | 448 |
4 | Chemistry, Organic | 1749 | 14% | 0% | 318 |
5 | Biophysics | 886 | 8% | 0% | 187 |
6 | Cell Biology | 758 | 11% | 0% | 257 |
7 | Rheumatology | 220 | 2% | 0% | 48 |
8 | Medicine, Research & Experimental | 111 | 4% | 0% | 88 |
9 | Endocrinology & Metabolism | 66 | 3% | 0% | 78 |
10 | Chemistry, Multidisciplinary | 61 | 7% | 0% | 153 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AB HANCOCK JR MEM CANC | 175488 | 1% | 40% | 33 |
2 | MEDIATOR SIGNAL TRANSDUCT PHARMACOL | 30207 | 0% | 57% | 4 |
3 | MOL BIOL 341 | 29737 | 0% | 75% | 3 |
4 | AB HANCOCK MEM CANC | 26434 | 0% | 100% | 2 |
5 | DIPARTIMENTO STUDI CHIM TECNOL FARM | 26434 | 0% | 100% | 2 |
6 | MED BIOCHEM MOL TOXICOL | 26434 | 0% | 100% | 2 |
7 | S NEPHROL | 26434 | 0% | 100% | 2 |
8 | TAKSHASHILA PARISAR | 26434 | 0% | 100% | 2 |
9 | DIPARTIMENTO STUDI CHIM TECNOL FARMACO | 26430 | 0% | 50% | 4 |
10 | HLTH SCI INTERNAL MED HEMATOL | 23788 | 0% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 14962 | 1% | 4% | 30 |
2 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 9963 | 2% | 2% | 37 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 9552 | 6% | 1% | 136 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY | 7945 | 4% | 1% | 89 |
5 | MEDICINAL CHEMISTRY RESEARCH | 6932 | 2% | 1% | 41 |
6 | INFLAMMATION RESEARCH | 4788 | 1% | 1% | 32 |
7 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 4367 | 2% | 1% | 56 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 3085 | 3% | 0% | 72 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 2592 | 8% | 0% | 180 |
10 | EXPERT OPINION ON THERAPEUTIC PATENTS | 2583 | 1% | 1% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE | 308946 | 12% | 8% | 285 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
2 | PROSTAGLANDIN H SYNTHASE | 202701 | 2% | 34% | 45 | Search PROSTAGLANDIN+H+SYNTHASE | Search PROSTAGLANDIN+H+SYNTHASE |
3 | COX 2 INHIBITORS | 169778 | 4% | 14% | 90 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
4 | COX 1 | 111621 | 2% | 16% | 54 | Search COX+1 | Search COX+1 |
5 | 1 5 DIARYLPYRAZOLES | 94066 | 0% | 65% | 11 | Search 1+5+DIARYLPYRAZOLES | Search 1+5+DIARYLPYRAZOLES |
6 | COX 2 | 89420 | 6% | 5% | 147 | Search COX+2 | Search COX+2 |
7 | PROSTAGLANDIN ENDOPEROXIDE SYNTHASE | 82223 | 1% | 27% | 23 | Search PROSTAGLANDIN+ENDOPEROXIDE+SYNTHASE | Search PROSTAGLANDIN+ENDOPEROXIDE+SYNTHASE |
8 | IMRECOXIB | 79302 | 0% | 100% | 6 | Search IMRECOXIB | Search IMRECOXIB |
9 | SELECTIVE COX 2 INHIBITORS | 78192 | 1% | 31% | 19 | Search SELECTIVE+COX+2+INHIBITORS | Search SELECTIVE+COX+2+INHIBITORS |
10 | CYCLOOXYGENASE 1 | 74487 | 2% | 15% | 38 | Search CYCLOOXYGENASE+1 | Search CYCLOOXYGENASE+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SMITH, WL , DEWITT, DL , GARAVITO, RM , (2000) CYCLOOXYGENASES: STRUCTURAL, CELLULAR, AND MOLECULAR BIOLOGY.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 69. ISSUE . P. 145 -182 | 123 | 50% | 1686 |
2 | KULMACZ, RJ , VAN DER DONK, WA , TSAI, AL , (2003) COMPARISON OF THE PROPERTIES OF PROSTAGLANDIN H SYNTHASE-1 AND -2.PROGRESS IN LIPID RESEARCH. VOL. 42. ISSUE 5. P. 377-404 | 127 | 82% | 50 |
3 | SMITH, WL , DEWITT, DL , (1996) PROSTAGLANDIN ENDOPEROXIDE H SYNTHASES-1 AND -2.ADVANCES IN IMMUNOLOGY, VOL 62. VOL. 62. ISSUE . P. 167-215 | 123 | 65% | 581 |
4 | ROUZER, CA , MARNETT, LJ , (2003) MECHANISM OF FREE RADICAL OXYGENATION OF POLYUNSATURATED FATTY ACIDS BY CYCLOOXYGENASES.CHEMICAL REVIEWS. VOL. 103. ISSUE 6. P. 2239-2304 | 127 | 70% | 129 |
5 | TSAI, AL , KULMACZ, RJ , (2010) PROSTAGLANDIN H SYNTHASE: RESOLVED AND UNRESOLVED MECHANISTIC ISSUES.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. VOL. 493. ISSUE 1. P. 103-124 | 98 | 78% | 47 |
6 | CHAKRABORTI, AK , GARG, SK , KUMAR, R , MOTIWALA, HF , JADHAVAR, PS , (2010) PROGRESS IN COX-2 INHIBITORS: A JOURNEY SO FAR.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 15. P. 1563-1593 | 105 | 70% | 61 |
7 | HERSCHMAN, HR , (1996) PROSTAGLANDIN SYNTHASE 2.BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM. VOL. 1299. ISSUE 1. P. 125-140 | 79 | 69% | 999 |
8 | SINGH, P , MITTAL, A , (2008) CURRENT STATUS OF COX-2 INHIBITORS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 1. P. 73-90 | 86 | 85% | 38 |
9 | SMITH, WL , GARAVITO, RM , DEWITT, DL , (1996) PROSTAGLANDIN ENDOPEROXIDE H SYNTHASES (CYCLOOXYGENASES)-1 AND -2.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 271. ISSUE 52. P. 33157 -33160 | 53 | 80% | 1471 |
10 | SMITH, WL , DEWITT, DL , (1995) BIOCHEMISTRY OF PROSTAGLANDIN ENDOPEROXIDE-H SYNTHASE-1 AND SYNTHASE-2 AND THEIR DIFFERENTIAL SUSCEPTIBILITY TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS.SEMINARS IN NEPHROLOGY. VOL. 15. ISSUE 3. P. 179-194 | 88 | 84% | 251 |
Classes with closest relation at Level 1 |